• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 prnewswire
    November 30, 2021
    Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.
  • Emmes Acquires Orphan Reach contractpharma
    May 13, 2021
    ​Emmes, a global, full-service CRO, has acquired Orphan Reach, a company headquartered in the UK with offices in Ireland, Germany, India, Canada, and the U.S., dedicated to clinical research in rare diseases.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service